EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report

Hishan Tharmaseelan, Christian Peter Jaworek, Peter Borchmann, Conrad-Amadeus Voltin, Martin Galler, Gareth J Veal, Louisa Lepkes, Björn Reusch, Clara Velmans, Christian Netzer, Wenyu Yang, Uwe Fuhr und 1 weitere

Cancer Chemotherapy and Pharmacology · 2026

DOI: 10.1007/s00280-026-04975-w ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2026. Verfasst von Hishan Tharmaseelan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düs…. Hauptthemen laut MEDLINE: Hodgkin Disease, Jaundice, Chronic Idiopathic, ATP-Binding Cassette, Sub-Family C Proteins, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dubin-Johnson syndrome (DJS) results from ABCC2/MRP2 mutations causing impaired biliary transport. MRP2 also mediates hepatic elimination of chemotherapeutic agents, yet no data exist on anthracycline-based chemotherapy in adult DJS patients. We report a 26-year-old male with advanced-stage classic Hodgkin lymphoma and DJS harboring a novel homozygous ABCC2 variant (c.2291G>A, p.Gly764Asp). After a pembrolizumab prephase, full-dose BrECADD was administered, and samples were taken for therapeutic drug monitoring (TDM), which demonstrated normal etoposide and doxorubicin pharmacokinetics. Complete metabolic remission was achieved without significant toxicity. This case demonstrates that TDM-guided, full-dose anthracycline-based chemotherapy is feasible in DJS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseJaundice, Chronic IdiopathicATP-Binding Cassette, Sub-Family C ProteinsAntineoplastic Combined Chemotherapy ProtocolsHumansMaleAdultMultidrug Resistance-Associated Protein 2EtoposideMutation

Stichwörter der Autor:innen

ABCC2BrECADDClassic Hodgkin lymphomaDubin-Johnson syndromeGenetic polymorphismsTherapeutic drug monitoring

Substanzen

Multidrug Resistance-Associated Protein 2ABCC2 protein, humanATP-Binding Cassette, Sub-Family C ProteinsEtoposide

Autor:innen und Institutionen

  • Faculty of Medicine and University Hospital of Cologne, Department I of Internal Medicine, and Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), German Hodgkin Study Group (GHSG), University of C…
  • Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Newcastle University Centre for Cancer, Newcastle University, Newcastle upon Tyne, UK.
  • Institute of Human Genetics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.
  • Clinical Pharmacology, Department I of Pharmacology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany.

Zitieren

APA

Tharmaseelan, H., Jaworek, C. P., Borchmann, P., Voltin, C. A., Galler, M., Veal, G. J., Lepkes, L., Reusch, B., Velmans, C., Netzer, C., Yang, W., Fuhr, U., & Barnett, S. (2026). Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-026-04975-w

Vancouver

Tharmaseelan H, Jaworek CP, Borchmann P, Voltin CA, Galler M, Veal GJ, et al. Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report. Cancer Chemotherapy and Pharmacology. 2026. doi:10.1007/s00280-026-04975-w

BibTeX
@article{Tharmaseelan2026,
  author = {Tharmaseelan, Hishan and Jaworek, Christian Peter and Borchmann, Peter and Voltin, Conrad-Amadeus and Galler, Martin and Veal, Gareth J and Lepkes, Louisa and Reusch, Björn and Velmans, Clara and Netzer, Christian and Yang, Wenyu and Fuhr, Uwe and Barnett, Shelby},
  title = {Successful treatment with BrECADD in a patient with Dubin-Johnson syndrome and classic Hodgkin lymphoma: a case report},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  doi = {10.1007/s00280-026-04975-w}
}
Kostenlos starten →